NCT02455271View on ClinicalTrials.gov

Investigation of the Safety and Efficacy of Long Term Administration of Eszopiclone in Insomnia Patients

CompletedOBSERVATIONAL

Enrollment

438

Participants

Timeline

Start Date

October 1, 2012

Primary Completion Date

March 30, 2015

Study Completion Date

December 22, 2015

Conditions

Insomnia

Interventions

DRUG

Eszopiclone

The usual dosage of eszopiclone is 2 mg per dose for adults and 1 mg per dose for elderly participants, taken orally before bedtime. The dosage may be adjusted according to the participant's symptoms, but a single dose should not exceed 3 mg in adults and 2 mg in elderly participants.

Trial Locations (2)

Unknown

Osaka

Tokyo

All Listed Sponsors

lead

Eisai Co., Ltd.

INDUSTRY

NCT02455271 - Investigation of the Safety and Efficacy of Long Term Administration of Eszopiclone in Insomnia Patients | Biotech Hunter | Biotech Hunter